FranciscoACastillosMD

Oncology • Wake Forest, NC

Hem/Onc Physician/Owner

Join to view full profile

Dr. Castillos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Castillos' full profile

Already have an account?

Office
11635 Nortpark Drive, Suite 250
Wake Forest, NC 27587
Phone+1 919-825-4637

Fax+1 919-562-0444

Summary

Dr. Francisco Castillos is an independent oncologist in Wake Forest, NC. He is not affiliated with any network or hospitals. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 22 years. He specializes in hematology, oncology and primary care. His clinic is a certified infusion center and treatments are not only for oncology but also for MS patients, RA patients, anemia patients.

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2001
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 1999
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1996 - 1998
Norwalk Hospital/Yale UniversityInternship, Internal Medicine, 1995 - 1996
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1995

Certifications & Licensure

NC State Medical License 2004 - 2025
VA State Medical License 1998 - 2010
KY State Medical License 1999 - 2002
AL State Medical License 1998 - 1999

Awards, Honors, & Recognition

MIPS 2018
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior Start of enrollment: 1998 Dec 01
Recruiting

Publications & Presentations

PubMed

9 citations
A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
Sara R. Rashkin, Katherina C. Chua, Carol Ho, Flora Mulkey, Chen Jiang
Clinical Pharmacology and Therapeutics. 2019-03-01
32 citations
Hagfish biopolymer: a type I/type II homologue of epidermal keratin intermediate filaments.
Elizabeth A. Koch, Robert H. Spitzer, Ron B. Pithawalla, Francisco A. Castillos, David A.D. Parry
International Journal of Biological Macromolecules. 1995-01-01

Journal Articles

A Pharmacogenetic Prediction Model of Progression‐Free Survival in Breast Cancer Using Genome‐Wide Genotyping Data from CALGB 40502 (Alliance)
Hope S Rugo, Francisco Castillos, Beth Overmoyer, Mark J Ratain, Clinical Pharmacology & Therapeutics